Real-world evidence of Nusinersen treatment for patients with spinal muscular atrophy in the Kingdom of Saudi Arabia

The study demonstrates that baseline and follow-up data from multiple motor and functional assessment scales were essential for evaluating disease progression and treatment response in SMA.

Authors

Institutions

Publication Details

Journal
Saudi Medical Journal
Published
2025-12-01
DOI
https://doi.org/10.15537/smj.2025.46.12.20250107
Primary Topic
Neurogenetic and Muscular Disorders Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Real-world evidence of Nusinersen treatment for patients with spinal muscular atrophy in the Kingdom of Saudi Arabia

Hajer Almudaiheem, Fowzia Ibrahim, Fahad A. Bashiri, Fouad Alghamdi et al.
Saudi Medical Journal
Neurogenetic and Muscular Disorders Research
article

Real-world evidence of Nusinersen treatment for patients with spinal muscular atrophy in the Kingdom of Saudi Arabia

Hajer Almudaiheem, Fowzia Ibrahim, Fahad A. Bashiri, Fouad Alghamdi, Ahmed Al‐Jedai, Tareef Alaama, Abdulaziz Alsaman, Aljohara A Alsakran, Mohammed Abdelrahman Almuhaizae, Eman Ahmed Yousef Matter
article en

Abstract

The study demonstrates that baseline and follow-up data from multiple motor and functional assessment scales were essential for evaluating disease progression and treatment response in SMA.

Saudi Medical JournalVol. 46(12)
King Faisal University (SA)
Openalex Percentile: Top 39%
Neurogenetic and Muscular Disorders Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.